… CTC-445.2d is a dimeric ACE2 mimic that has been shown to protect SARS-CoV-2-infected …
supports a role for IFNs in protection against SARS-CoV-2. SARS-CoV-2 infection has been …

… As a complementary intervention, specific SARS-CoV-2 antivirals may provide protection
in individuals at high risk for contagion and/or for developing severe COVID-19. Waning of …

… Although either IFNα/β or IFN-λ can confer antiviral protection, the tissue and dose of …
SARS-CoV-2 inhibits the expression and distribution of IFNLR1, which confers antiviral protection …

… antiviral properties and are presumed to inhibit SARS-CoV-2. … agent against SARS-CoV-2,
we evaluated the antiviral effect of … protect VeroE6/TMPRSS2 cells from SARS-CoV-2 infection …

… SARS-CoV-2 M pro (11–13) and our cocrystal structures of SARS-CoV-2 M pro in complex
with the approved antivirals … ’ cellular antiviral activity was examined by a cell protection assay…

… protect and be sterilized against SARS-CoV-2 [43,44]. Even biopolymers in nano-assemblies
have been reported to generate potential antiviral … can neutralize the SARS-CoV-2 (Figure 3…

… Here, we developed a neutralization assay using SARS-CoV-2 … of SARS-CoV-2-infected
patients. We also screened 136 safe-in-man broad-spectrum antivirals against the SARS-CoV-2 …

… -2, our findings raise the possibility that people with asymptomatic SARS-CoV-2 infection
may have less protection from re-infection after primary infection. The timing of infection onset …

… Passive transfer of sera from mice that were previously infected with SARS-CoV protected
naïve mice from SARS-CoV intranasal challenge [23]. Furthermore, recombinant protein …

… -term antiviral protection against SARS-CoV-2 infection, and it has great potential as a
broad-spectrum approach to constrain the spread of newly emerging viruses until virus-specific …